Form 4: CareDx Director William Hagstrom Reports Acquisition of Common Stock and Stock Options
SEC Form 4 Filing
Director William Hagstrom reports acquisition of 10,570 shares of common stock and 16,048 stock options in CareDx, Inc.
Summary
- On June 14, 2024, William A. Hagstrom, a director of CareDx, Inc. (CDNA), acquired 10,570 shares of common stock.
- These shares were acquired through restricted stock units that will vest on June 14, 2025.
- Additionally, Hagstrom acquired 16,048 stock options with an exercise price of $9.3469.
- These options vest monthly, starting July 14, 2024, and continuing through June 14, 2025.
- Following these transactions, Hagstrom beneficially owns 53,979 shares of common stock and 16,048 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports routine insider transactions. It doesn't inherently indicate positive or negative performance, but rather provides transparency.
Positives
- The acquisition of shares and options by a director may signal confidence in the company's future prospects.
Future Outlook
The restricted stock units vest on June 14, 2025, and the stock options vest monthly from July 14, 2024, to June 14, 2025.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Comparison to Industry Standards
- Insider transactions are a normal part of corporate governance and are regularly disclosed by directors and officers of publicly traded companies.
- The vesting schedules for the restricted stock units and stock options are typical compensation mechanisms used to align the interests of management with those of shareholders.
- Similar transactions are frequently observed in companies like Exact Sciences (EXAS) and Natera (NTRA), which operate in related fields within the diagnostics industry.
Stakeholder Impact
- Shareholders are informed about the transactions of a key company director, providing transparency into insider activity.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 07/14/2024 | First vesting date for 1/12th of the stock options. |
| 06/14/2025 | Vesting date for the restricted stock units and final vesting date for the stock options. |
| 06/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.